EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

YAP/TAZ‐TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma

Kostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou iD

Journal of Cellular and Molecular Medicine · 2024-04 · 28 (8)

DOI: 10.1111/jcmm.18330 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 12.04.2024. Verfasst von Kostas A Papavassiliou und 2 weiteren Autor:innen. Beteiligte Einrichtung: First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Gree…. Hauptthemen laut MEDLINE: Mesothelioma, Malignant, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Hippo signalling pathway, a highly conserved signalling cassette, regulates organ size by controlling cell growth, apoptosis and stem cell self‐renewal. The tumourigenic potential of this pathway is largely attributed to the activity of YAP/TAZ, which activate the TEAD1‐4 transcription factors, leading to the expression of genes involved in cell proliferation and suppression of cell death. Aberrant regulation of the YAP/TAZ‐TEAD signalling axis is commonly observed in malignant pleural mesothelioma (MPM), an insidious neoplasm of the pleural tissue that lines the chest cavity and covers the lungs with poor prognosis. Given the limited effectiveness of current treatments, targeting the YAP/TAZ‐TEAD signalling cascade has emerged as a promising therapeutic strategy in MPM. Several inhibitors of the YAP/TAZ‐TEAD signalling axis are presently undergoing clinical development, with the goal of advancing them to clinical use in the near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesothelioma, MalignantNeoplasmsHumansSignal TransductionTranscription FactorsHippo Signaling Pathway

Stichwörter der Autor:innen

Hippo signallingTEADTEAD inhibitorYAP/TAZmalignant pleural mesothelioma

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

ORCID-Profile: Athanasios G Papavassiliou

Zitieren

APA

Papavassiliou, K. A., Sofianidi, A. A., & Papavassiliou, A. G. (2024). YAP/TAZ‐TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma. Journal of Cellular and Molecular Medicine, 28(8). https://doi.org/10.1111/jcmm.18330

Vancouver

Papavassiliou KA, Sofianidi AA, Papavassiliou AG. YAP/TAZ‐TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma. Journal of Cellular and Molecular Medicine. 2024;28(8). doi:10.1111/jcmm.18330

BibTeX
@article{Papavassiliou2024,
  author = {Papavassiliou, Kostas A and Sofianidi, Amalia A and Papavassiliou, Athanasios G},
  title = {YAP/TAZ‐TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  volume = {28},
  number = {8},
  doi = {10.1111/jcmm.18330}
}
Kostenlos starten →